查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130820

智慧型血糖監測儀市場分析與預測（至2035年）：類型、產品、服務、技術、組件、應用、最終用戶、功能、解決方案

Smart Blood Glucose Monitors Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球智慧型血糖監測儀市場預計將從2025年的18億美元成長到2035年的40億美元，複合年成長率（CAGR）為8.3%。全球對智慧型血糖監測儀的潛在需求主要受糖尿病患者數量龐大且持續成長的推動。根據國際糖尿病聯盟（IDF）估計，2024年全球20至79歲成年人中，糖尿病患者人數為5.89億，預計到2050年將達到8.53億人。糖尿病在主要市場普遍流行，從而持續推動了對監測技術和互聯醫療解決方案的需求。據估計，到2024年，約有42.8%的糖尿病患者仍未被確診，這凸顯了診斷、監測和疾病管理基礎設施的巨大發展機會。此外，技術應用正朝著即時感測器、智慧型手機整合、自動警報和數位化整合監測生態系統的方向發展。

持續血糖監測儀 (CGM) 透過穿戴式或植入式感測器持續測量組織液中的血糖水平，並將測量結果、趨勢和警報傳輸到連接的顯示器或智慧型手機。瞬感血糖監測儀也採用基於感測器的測量方法，但通常需要使用者掃描感測器才能獲得測量結果。然而，新型系統擴大具備自動資料傳輸功能。這兩種技術都減少了對傳統指尖採血的依賴，提高了血糖值波動的可視性，並支持及時的治療性介入。 CGM 特別適用於強化糖尿病管理和自動胰島素輸注系統，而瞬感血糖監測儀則優先考慮便利性、降低操作負擔和經濟性。更長的感測器佩戴時間、智慧型手機連接以及改進的演算法分析功能正在推動其更廣泛的應用。

市場區隔
類型 連續血糖監測儀、瞬感血糖監測儀及其他
產品 穿戴式裝置、非穿戴式裝置、其他
服務 遠端監控、資料管理、諮詢服務等。
科技 藍牙、Wi-Fi、近距離場通訊 (NFC)、雲端、其他
成分 感測器、發送器、接收器及其他
目的 1型糖尿病、第2型糖尿病、妊娠糖尿病及其他
最終用戶 醫院、居家醫療、診所、門診手術中心及其他機構
功能 即時監測、間歇監測等。
解決方案 整合系統、獨立系統及其他

手持式血糖儀包括小型血糖儀和連網監測單元，旨在直接測量、數據儲存和顯示，通常使用血液樣本和一次性試紙。可攜式血糖儀透過輕巧的結構、無線連接、智慧型手機同步、雲端數據共用和穿戴式感測器介面擴展了這些功能。手持式血糖儀因其成熟的臨床工作流程、價格優勢和用戶熟悉度而仍然十分重要，而可攜式智慧型系統則越來越重視行動性、自動數據收集以及與數位糖尿病管理平台的整合。製造商正致力於提高電池效率、連接性、感測器小型化和使用者介面，以增強其在臨床環境之外的易用性。對家庭監測、遠端患者管理和個人化血糖值分析日益成長的需求正在推動市場成長。

區域概覽

北美憑藉其先進的醫療保健基礎設施、高額的糖尿病管理支出、完善的保險報銷機制以及互聯醫療設備的廣泛應用，在智慧血糖監測領域保持著強勁的競爭力。尤其值得一提的是，美國擁有高度成熟的生態系統，涵蓋感測器製造商、數位健康平台、內分泌網路、藥房和遠端患者監護服務提供者。美國食品藥物管理局(FDA) 的監管流程正在推動日益整合的持續血糖監測 (CGM) 技術的商業化，其中包括旨在取代特定患者群體指尖採血檢測的系統。智慧型手機的連結性、與胰島素輸注系統的互通性以及消費者獲取管道的增加，都在推動市場需求。近期監管政策的進展和產品創新不斷鞏固該地區的技術領先地位。

由於主要經濟體糖尿病盛行率不斷上升、醫療保健數位化以及對慢性病管理投入的增加，亞太地區蘊藏著巨大的成長潛力。預計到2024年，光是東南亞地區就將有1.07億成年糖尿病患者，為便捷的監測解決方案提供了龐大的患者族群。印度、中國、日本和其他區域市場正在加速採用互聯醫療技術、行動醫療應用程式和家庭監測設備。製造商正日益致力於開發適用於各種醫療環境的攜帶式、經濟高效的設備，並輔以數位連接功能，以實現遠距醫療和數據共用。診斷率的提高、醫療基礎設施的改善、在地化生產措施以及人們對糖尿病管理意識的增強，預計將推動市場的持續發展。

主要趨勢和促進因素

智慧血糖監測正發展成為互聯互通的連續性糖尿病照護：

市場正朝著整合、微創且全天候的血糖監測生態系統轉型，該系統融合了感測器、智慧型手機、雲端平台、預測分析和自動警報功能。製造商正不斷延長感測器佩戴時間，提升互通性，減輕用戶負擔，並將血糖數據整合到更廣泛的數位健康平台中。近期趨勢也凸顯了多生物標記監測的趨勢，印證了業界正從單一設備血糖監測轉向全面、即時的代謝管理。

糖尿病負擔日益加重，加速了智慧血糖監測的需求：

全球糖尿病負擔日益加重，對可靠、頻繁且便利的血糖監測的需求也日益成長，無論是在家中還是在臨床環境中。全球數億成年人患有糖尿病，其中許多人尚未確診，因此醫療保健系統需要相關技術來支援早期發現、持續疾病管理和個人化治療決策。智慧血糖監測儀透過提供趨勢資訊、警報和數位化數據來滿足這些需求，同時減少對傳統人工檢測的依賴。醫療保健的日益數位化和遠端患者管理的擴展進一步推動了對互聯監測解決方案的需求。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 持續血糖監測
    • 瞬時血糖監測儀
    • 其他
  • 市場規模及預測：依產品分類
    • 穿戴式裝置
    • 非穿戴式裝置
    • 其他
  • 市場規模及預測：依服務分類
    • 遠端監控
    • 資料管理
    • 諮詢服務
    • 其他
  • 市場規模及預測：依技術分類
    • Bluetooth
    • Wi-Fi
    • 近距離場通訊（NFC）
    • 基於雲端的
    • 其他
  • 市場規模及預測：依組件分類
    • 感應器
    • 發送器
    • 接收器
    • 其他
  • 市場規模及預測：依應用領域分類
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 居家照護環境
    • 診所
    • 門診手術中心
    • 其他
  • 市場規模及預測：依功能分類
    • 即時監控
    • 間歇性監測
    • 其他
  • 市場規模及預測：按解決方案分類
    • 整合系統
    • 獨立系統
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Roche
  • Abbott Laboratories
  • Dexcom
  • Medtronic
  • Ascensia Diabetes Care
  • LifeScan
  • Sanofi
  • Novo Nordisk
  • Bayer
  • Johnson and Johnson
  • Terumo Corporation
  • B. Braun Melsungen
  • Ypsomed
  • Nipro Corporation
  • AgaMatrix
  • Arkray
  • Trividia Health
  • GlucoMe
  • iHealth Labs
  • DarioHealth

第9章 關於我們

簡介目錄
Product Code: GIS11097

The global Smart Blood Glucose Monitors Market is projected to grow from $1.8 billion in 2025 to $4.0 billion by 2035, at a compound annual growth rate (CAGR) of 8.3%. The global addressable demand for smart glucose monitoring is supported by a substantial and expanding diabetes population. The International Diabetes Federation estimates that 589 million adults aged 2079 were living with diabetes worldwide in 2024, with the total projected to reach 853 million by 2050. Diabetes prevalence is distributed across major markets, creating sustained demand for monitoring technologies and connected care solutions. Approximately 42.8% of adults with diabetes were estimated to remain undiagnosed in 2024, highlighting continuing opportunities for diagnosis, monitoring, and disease-management infrastructure. Technological adoption is also moving toward real-time sensors, smartphone connectivity, automated alerts, and digitally integrated monitoring ecosystems.

Continuous Glucose Monitors continuously measure glucose concentrations in interstitial fluid through wearable or implantable sensors, transmitting readings, trends, and alerts to connected displays or smartphones. Flash Glucose Monitors similarly use sensor-based measurements but typically require users to scan the sensor to retrieve readings, although newer systems increasingly provide automatic data transmission. Both technologies reduce dependence on conventional finger-stick testing, improve visibility into glucose variability, and support timely therapeutic interventions. CGMs are particularly suited to intensive diabetes management and automated insulin delivery ecosystems, while flash systems emphasize convenience, lower interaction burden, and affordability. Expanding sensor wear duration, smartphone integration, and algorithmic analytics are supporting broader adoption.

Market Segmentation
TypeContinuous Glucose Monitors, Flash Glucose Monitors, Others
ProductWearable Devices, Non-Wearable Devices, Others
ServicesRemote Monitoring, Data Management, Consultation Services, Others
TechnologyBluetooth, Wi-Fi, Near Field Communication (NFC), Cloud-Based, Others
ComponentSensors, Transmitters, Receivers, Others
ApplicationType 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others
End UserHospitals, Homecare Settings, Clinics, Ambulatory Surgical Centers, Others
FunctionalityReal-Time Monitoring, Intermittent Monitoring, Others
SolutionsIntegrated Systems, Standalone Systems, Others

Handheld devices comprise compact glucose meters and connected monitoring units designed for direct measurement, data storage, and display, commonly using blood samples and disposable test strips. Portable devices extend this functionality through lightweight architectures, wireless connectivity, smartphone synchronization, cloud-based data sharing, and wearable sensor interfaces. Handheld monitors remain relevant because of established clinical workflows, affordability, and familiarity, while portable smart systems increasingly emphasize mobility, automated data capture, and integration with digital diabetes-management platforms. Manufacturers are improving battery efficiency, connectivity, sensor miniaturization, and user interfaces to strengthen usability outside clinical environments. Growth is supported by increasing demand for home-based monitoring, remote patient management, and personalized glucose insights.

Geographical Overview

North America maintains a strong position in smart blood glucose monitoring due to advanced healthcare infrastructure, high diabetes-management expenditure, established reimbursement pathways, and substantial adoption of connected medical devices. The United States provides a particularly mature ecosystem encompassing sensor manufacturers, digital-health platforms, endocrinology networks, pharmacies, and remote patient monitoring providers. Regulatory pathways from the U.S. Food and Drug Administration support commercialization of increasingly integrated CGM technologies, including systems designed to replace finger-stick testing in appropriate patient populations. Smartphone connectivity, interoperability with insulin-delivery systems, and expanding consumer access are strengthening demand. Recent regulatory activity and product innovation continue to reinforce the region's technological leadership.

Asia Pacific presents substantial expansion potential as diabetes prevalence, healthcare digitization, and investment in chronic-disease management increase across major economies. South-East Asia alone accounted for an estimated 107 million adults with diabetes in 2024, creating a considerable patient base for accessible monitoring solutions. India, China, Japan, and other regional markets are witnessing greater deployment of connected healthcare technologies, mobile health applications, and home-based monitoring. Manufacturers are increasingly targeting portable and cost-efficient devices suited to diverse healthcare environments, while digital connectivity supports remote consultations and data sharing. Rising diagnosis rates, improving healthcare infrastructure, local manufacturing initiatives, and broader awareness of diabetes management are expected to support continued market development.

Key Trends and Drivers

Smart Glucose Monitoring Moves Toward Connected and Continuous Diabetes Care:

The market is shifting toward integrated, minimally invasive, and continuously connected glucose-monitoring ecosystems that combine sensors, smartphones, cloud platforms, predictive analytics, and automated alerts. Manufacturers are extending sensor wear duration, improving interoperability, and reducing user intervention while increasingly incorporating glucose data into broader digital-health platforms. Recent device development also demonstrates movement toward multi-biomarker monitoring, reinforcing the industry's transition from standalone glucose measurement toward comprehensive, real-time metabolic management.

Rising Diabetes Burden Accelerates Demand for Intelligent Glucose Monitoring:

The expanding global burden of diabetes is increasing the need for reliable, frequent, and convenient glucose monitoring across home and clinical settings. With hundreds of millions of adults affected worldwide and significant numbers remaining undiagnosed, healthcare systems require technologies that support earlier detection, continuous disease management, and individualized treatment decisions. Smart monitors address these requirements by providing trend information, alerts, and digitally accessible data, while reducing dependence on conventional manual testing. Increasing healthcare digitization and remote patient management are further strengthening demand for connected monitoring solutions.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Continuous Glucose Monitors
    • 4.1.2 Flash Glucose Monitors
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Wearable Devices
    • 4.2.2 Non-Wearable Devices
    • 4.2.3 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Remote Monitoring
    • 4.3.2 Data Management
    • 4.3.3 Consultation Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Bluetooth
    • 4.4.2 Wi-Fi
    • 4.4.3 Near Field Communication (NFC)
    • 4.4.4 Cloud-Based
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Transmitters
    • 4.5.3 Receivers
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Type 1 Diabetes
    • 4.6.2 Type 2 Diabetes
    • 4.6.3 Gestational Diabetes
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Homecare Settings
    • 4.7.3 Clinics
    • 4.7.4 Ambulatory Surgical Centers
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Real-Time Monitoring
    • 4.8.2 Intermittent Monitoring
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Integrated Systems
    • 4.9.2 Standalone Systems
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Roche
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Abbott Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Dexcom
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Medtronic
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Ascensia Diabetes Care
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 LifeScan
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Sanofi
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Novo Nordisk
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Bayer
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Johnson and Johnson
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Terumo Corporation
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 B. Braun Melsungen
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Ypsomed
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Nipro Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 AgaMatrix
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Arkray
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Trividia Health
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 GlucoMe
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 iHealth Labs
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 DarioHealth
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us